2025-525125-12-00CompletedPhase 1
A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults
Source: EU CTIS (euclinicaltrials.eu) · Last updated 3 Aug 2026
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- First submitted
- 16 Mar 2026
- Start date
- 5 May 2026
- Lead sponsor
- Pfizer Inc.
- EU CT number
- 2025-525125-12-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 36
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pfizer Clinical Research Unit | Brussels | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.